NovoCure (NVCR) Stock Chart & Stock Price History → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free NVCR Stock Alerts $15.79 +0.26 (+1.67%) (As of 11:33 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability NovoCure Stock Price Performance5 Day Performance+6.83%1 Month Performance+11.35%3 Month Performance+6.33%6 Month Performance+30.93%Year-To-Date Performance+5.76%1 Year Performance-77.24% Receive NVCR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NovoCure and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. NVCR Stock Chart for Wednesday, May, 8, 2024 NVCR Chart by TradingView NovoCure Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$15.55$15.53-0.13%$16.25$15.31904,367 shs$1.67 billion05/06/2024$14.78$15.55+5.21%$15.75$14.851.28 million shs$1.67 billion05/03/2024$14.19$14.78+4.16%$15.42$14.311.15 million shs$1.59 billion05/02/2024$12.74$14.19+11.38%$14.21$12.171.57 million shs$1.53 billion05/01/2024$12.24$12.74+4.08%$13.26$12.241.29 million shs$1.37 billion04/30/2024$12.80$12.24-4.38%$12.66$12.211.08 million shs$1.32 billion Get the Latest News and Ratings for NVCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NovoCure and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$12.64$12.80+1.31%$13.02$12.691.07 million shs$1.38 billion04/26/2024$12.23$12.64+3.31%$12.65$12.01761,583 shs$1.36 billion04/25/2024$12.34$12.23-0.89%$12.37$11.881.15 million shs$1.32 billion04/24/2024$12.06$12.34+2.36%$12.39$12.021.32 million shs$1.33 billion04/23/2024$11.83$12.06+1.90%$12.46$11.70839,660 shs$1.30 billion04/22/2024$12.09$11.83-2.15%$12.13$11.70806,306 shs$1.27 billion04/19/2024$12.05$12.09+0.33%$12.32$11.89850,396 shs$1.30 billion04/18/2024$12.05$12.05$12.45$11.891.39 million shs$1.30 billion04/17/2024$12.46$12.05-3.29%$12.45$12.041.36 million shs$1.30 billion04/16/2024$12.72$12.46-2.04%$12.58$12.20923,276 shs$1.33 billion04/15/2024$13.57$12.72-6.26%$13.72$12.641.17 million shs$1.36 billion04/12/2024$14.12$13.57-3.90%$14.12$13.40901,665 shs$1.45 billion04/11/2024$14.62$14.12-3.42%$15.00$14.03830,644 shs$1.51 billion04/10/2024$14.88$14.62-1.75%$14.74$14.11953,715 shs$1.57 billion04/09/2024$14.18$14.88+4.94%$15.46$14.19969,498 shs$1.59 billion04/08/2024$13.74$14.18+3.20%$14.21$13.621.13 million shs$1.52 billion04/05/2024$14.29$13.74-3.85%$14.24$13.621.39 million shs$1.47 billion04/04/2024$14.42$14.29-0.90%$14.79$14.221.01 million shs$1.53 billion04/03/2024$14.39$14.42+0.21%$14.78$14.001.36 million shs$1.54 billion04/02/2024$15.49$14.39-7.10%$15.15$14.071.39 million shs$1.54 billion04/01/2024$15.63$15.49-0.90%$15.63$14.981.67 million shs$1.66 billion03/29/2024$15.63$15.63$16.05$14.382.81 million shs$1.67 billion03/28/2024$14.64$15.63+6.76%$16.05$14.382.81 million shs$1.67 billion03/27/2024$13.07$14.64+12.01%$15.49$12.9211.93 million shs$1.57 billion03/26/2024$13.20$13.07-0.98%$13.57$13.041.09 million shs$1.40 billion03/25/2024$13.21$13.20-0.08%$13.60$12.901.38 million shs$1.41 billion03/22/2024$13.95$13.21-5.30%$13.95$13.08953,213 shs$1.41 billion03/21/2024$13.63$13.95+2.35%$14.04$13.55843,231 shs$1.49 billion03/20/2024$13.54$13.63+0.66%$13.85$13.26988,494 shs$1.46 billion03/19/2024$13.82$13.54-2.03%$13.97$13.461.08 million shs$1.45 billion03/18/2024$13.98$13.82-1.14%$14.32$13.811.09 million shs$1.48 billion03/15/2024$14.61$13.98-4.31%$14.66$13.911.26 million shs$1.50 billion03/14/2024$14.82$14.61-1.42%$14.94$14.45832,759 shs$1.56 billion03/13/2024$15.29$14.82-3.07%$15.74$14.75763,979 shs$1.59 billionFidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>>03/12/2024$15.99$15.29-4.38%$15.90$14.931.07 million shs$1.64 billion03/11/2024$16.54$15.99-3.33%$16.89$15.871.13 million shs$1.71 billion03/08/2024$17.29$16.54-4.34%$18.04$16.521.04 million shs$1.77 billion03/07/2024$16.65$17.29+3.84%$17.40$16.65894,268 shs$1.85 billion03/06/2024$16.30$16.65+2.15%$16.74$16.35530,802 shs$1.78 billion03/05/2024$16.43$16.30-0.79%$16.58$16.06544,458 shs$1.75 billion03/04/2024$16.25$16.43+1.11%$16.58$15.88699,195 shs$1.76 billion03/01/2024$15.31$16.25+6.14%$16.31$15.191.01 million shs$1.74 billion02/29/2024$16.02$15.31-4.43%$16.45$15.141.70 million shs$1.64 billion02/28/2024$16.30$16.02-1.72%$16.47$15.96958,511 shs$1.72 billion02/27/2024$14.90$16.30+9.40%$16.49$15.181.40 million shs$1.75 billion02/26/2024$15.22$14.90-2.10%$15.24$14.701.23 million shs$1.60 billion02/23/2024$15.24$15.22-0.13%$15.76$14.861.46 million shs$1.63 billion02/22/2024$15.62$15.24-2.43%$17.00$14.501.32 million shs$1.63 billion02/21/2024$15.82$15.62-1.26%$15.77$15.16988,336 shs$1.67 billion02/20/2024$16.14$15.82-1.98%$16.24$15.601.14 million shs$1.69 billion02/19/2024$16.14$16.14$16.99$15.541.36 million shs$1.72 billion02/16/2024$15.93$16.14+1.32%$16.99$15.541.36 million shs$1.72 billion02/15/2024$15.62$15.93+1.98%$16.15$15.28804,172 shs$1.70 billion02/14/2024$14.92$15.62+4.69%$15.73$15.011.03 million shs$1.67 billion02/13/2024$16.10$14.92-7.33%$15.64$14.75907,466 shs$1.59 billion02/12/2024$15.31$16.10+5.16%$16.14$15.291.16 million shs$1.72 billion02/09/2024$14.85$15.31+3.10%$15.40$14.811.10 million shs$1.64 billion02/08/2024$14.96$14.85-0.74%$15.47$14.651.00 million shs$1.59 billion02/07/2024$14.87$14.96+0.61%$15.48$14.631.07 million shs$1.60 billion Related Companies: LeMaitre Vascular Stock Price Chart Alphatec Stock Price Chart Integra LifeSciences Stock Price Chart MiMedx Group Stock Price Chart AtriCure Stock Price Chart Artivion Stock Price Chart Paragon 28 Stock Price Chart ICU Medical Stock Price Chart Inari Medical Stock Price Chart OrthoPediatrics Stock Price Chart Receive NVCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NovoCure and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NVCR) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovoCure Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.